1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Baseline characteristics in patients with MMD with and without recurrent ipsilateral hemorrhage
Characteristic Patients without Recurrent Hemorrhage (n = 20) Patients with Recurrent Hemorrhage (n = 19) P Value Women (No.) (%) 15 (75.0) 14 (73.7) .93 Age (mean) (yr) 43.7 ± 10.6 46.9 ± 7.0 .27 Smokers (No.) (%) 1 (5.0) 1 (5.3) >.99 Concurrent disease (No.) (%) Hypertension 8 (40.0) 5 (26.3) .37 Dyslipidemia 4 (20.0) 4 (21.1) >.99 Diabetes mellitus 2 (10.0) 1 (5.3) >.99 History of ischemia (No.) (%) 1 (5.0) 2 (10.5) .61 Hemorrhagic type (No.) (%) IVH 13 (65.0) 13 (68.4) .82 Only IVH 6 (30.0) 10 (52.6) .20 ICH + IVH 7 (35.0) 3 (15.8) .46 SAH 0 (0.0) 4 (21.1) .05 Only SAH 0 (0.0) 1 (5.3) .49 SAH + IVH 0 (0.0) 3 (15.8) .27 ICH 7 (35.0) 2 (10.5) .13
Note:—IVH, intraventricular hemorrhage; ICH, intracerebral hemorrhage.